The firm last week announced it received funding that will allow it to complete development of the test, called Myelo-Scan, by the end of 2026.

The global flow cytometry market size is rising from USD 5.70 billion in 2024 to USD 11.21 billion by 2033 with a compound annual growth rate (CAGR) of 7.80% from 2024 to 2033. The flow cytometry ...

The past decade has seen an increase in variable antifungal resistance rates among human fungal pathogens, necessitating individual isolate testing. Various antifungal ... and subject to trailing ...

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, clinically aggressive tumor derived from the precursors of plasmacytoid dendritic cells (PDCs). The patient was diagnosed with BPDCN ...

Activation of macrophage TLR4 by bacterial endotoxins is important for the progression of sepsis, but the underlying ...